Reboot Rx Inc (EIN 844384737) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2020

Legal Domicile

Principal Officer

David Noymer

Phone

6178070687

Tax Period

2024-07-01 to 2025-06-30

Reboot Rx Inc, founded in 2020, is a community nonprofit in the Medical Research sector that reported $1.0M in total revenue in fiscal year 2024. Revenue fell 61% from the prior year — a significant decline worth monitoring. Expenses of $1.5M exceeded revenue, resulting in a 39% operating deficit.

Mission

Reboot Rx is a nonprofit that expands access to affordable cancer treatments by repurposing generic drugs.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $949,700

Program Service Revenue $0

Investment Income $97,849

Other Revenue $0

TOTAL REVENUE $1,047,549

Expense Breakdown

Grants Paid $0

Salaries & Benefits $1,195,138

Fundraising Expenses $37,244

Program Expenses $1,193,796

Other Expenses $260,848

TOTAL EXPENSES $1,455,986

Year-over-Year Comparison

	2024	2023	Change
Revenue	$1,047,549	$2,702,361	-0.6%
Expenses	$1,455,986	$974,789	+0.5%
Net Income	$-408,437	$1,727,572	-1.2%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$167,729

Total Directors

$167,729

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
Laura Kleiman	President CEO and Director	40.00	Officer Director	$161,692	$6,037	$167,729
Sherif Botros	VP of Data Science	40.00	Highest	$159,481	$6,362	$165,843
Mason Irving III	Director	2.00	Director	$0	$0	$0
Robert Pozen	Director	2.00	Director	$0	$0	$0
Lara Metcalf	Director	2.00	Director	$0	$0	$0
Ruchika Kumar	Director	2.00	Director	$0	$0	$0
Andrea Pollinger	Board Chair and Clerk	2.00	Officer Director	$0	$0	$0
David Noymer	Treasurer	2.00	Officer Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$1,047,549	$1,455,986	$2,202,529	$-408,437
2024	$2,702,361	$974,789	$2,559,533	$1,727,572
2023	$520,612	$591,050	$982,557	$-70,438
2022	$294,776	$461,492	$872,303	$-166,716
2021	$226,675	$515,387	$1,038,010	$-288,712
2020	$1,354,675	$32,070	$1,323,965	$1,322,605

Reboot Rx Inc